Upgrade Your Browser
We no longer support this version of your browser.
We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.
Return to the course you were viewing
You'll see two new oral cancer drugs, Nexavar and Sutent.
These drugs work similarly to Gleevec (imatinib). They block proteins involved in a tumor's growth and blood supply.
But Nexavar and Sutent target a wider range of proteins.
Pharmacist's Letter includes:
Already a subscriber? Log in
Volume pricing available. Get a quote